Taylor Schreiber
Founder bij SHATTUCK LABS, INC.
Vermogen: 25 M $ op 31-03-2024
Profiel
Taylor H.
Schreiber is the founder.
He founded Shattuck Labs, Inc. in 2016 and currently holds the title of Chief Executive Officer & Director.
He also held the position of Director at Pelican Therapeutics, Inc. from 2011 to 2017.
Additionally, he served as the Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Dr. Schreiber has an undergraduate degree from Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SHATTUCK LABS, INC.
5.81% | 12-01-2024 | 2 757 686 ( 5.81% ) | 25 M $ | 31-03-2024 |
Actieve functies van Taylor Schreiber
| Bedrijven | Functie | Begin |
|---|---|---|
| SHATTUCK LABS, INC. | Founder | 01-01-2016 |
Eerdere bekende functies van Taylor Schreiber
| Bedrijven | Functie | Einde |
|---|---|---|
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Director/Board Member | 01-01-2017 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31-12-2016 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Taylor Schreiber
| Bucknell University | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
